Its antacid effect depends on a reaction with gastric hydrochloric acid. This reaction produces magnesium chloride and water, consuming acid and raising gastric pH. The resulting change in acidity explains its relevance to acid-related discomfort, while also showing why the compound’s action in the stomach differs from its water-retaining effect in the intestine.
In the intestine, magnesium salts are poorly absorbed, so they remain within the lumen and retain water. The added water softens stool and promotes bowel movements. This osmotic action is pharmacologically distinct from acid neutralization: one changes the intestinal fluid environment, whereas the other reduces gastric acidity through a chemical reaction.
Reduced kidney function can limit magnesium clearance, allowing magnesium to accumulate and increasing the risk of hypermagnesemia. Consequently, patient factors must influence medication selection and counseling rather than relying only on the intended antacid or laxative effect. Kidney status is especially relevant because the compound supplies magnesium while clearance helps determine systemic exposure.
Dosing and onset depend on whether the medicine is being used for acid-related discomfort or occasional constipation, because these uses rely on different pharmacological actions. Patient factors also modify the expected response and safety profile. Pharmacology-based counseling should therefore connect the selected indication with the anticipated effect instead of treating dosing as identical across uses.
Selection should begin with the treatment goal, distinguishing acid-related discomfort from occasional constipation. Clinicians should then consider relevant patient factors, particularly kidney function, because impaired magnesium clearance may increase hypermagnesemia risk. This approach supports safer medication choice and counseling while acknowledging that effects, onset, dosing, and adverse reactions vary with the indication.
Counseling should explain that the same compound can produce different outcomes according to its site and mechanism of action. Gastric acid neutralization supports relief of acid-related discomfort, whereas intestinal water retention promotes bowel movements. Patients also need indication-specific expectations about onset and dosing, along with attention to kidney function and possible adverse reactions.